Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1160

1.

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S.

Am J Kidney Dis. 2015 Jun;65(6):878-88. doi: 10.1053/j.ajkd.2015.01.008. Epub 2015 Mar 19.

PMID:
25799137
2.

Laboratory diagnostics of chronic kidney disease in Croatia: state of the art.

Biljak VR, Honović L, Matica J, Knežević B, Vojak SŠ.

Biochem Med (Zagreb). 2015;25(1):73-83. doi: 10.11613/BM.2015.009.

3.

Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study.

Vejakama P, Ingsathit A, Attia J, Thakkinstian A.

Medicine (Baltimore). 2015 Jan;94(4):e475. doi: 10.1097/MD.0000000000000475.

PMID:
25634196
4.

Rituximab as a rescue therapy in patients with glomerulonephritis.

Souqiyyeh MZ, Shaheen FA, Alsuwaida A, Alghonaim M, Alwakeel J, Mosa D, Akhtar F, Rahman E, Husain M, Roujouleh H, Siddiqi N, Bukhari I, Sadaqa N, Mushtaque F, Awn NM, Shariya F, Alfi A, Amin M, Ahmad M, Rowaie FA, Almueilo S, Kechrid MC, Karkar A.

Saudi J Kidney Dis Transpl. 2015 Jan;26(1):47-55.

5.

Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.

Genctoy G, Arikan S, Gedik O.

Int Urol Nephrol. 2015 Feb;47(2):353-8. doi: 10.1007/s11255-014-0889-5. Epub 2014 Dec 24.

PMID:
25537827
6.

Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).

Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ.

Am J Kidney Dis. 2015 Mar;65(3):394-402. doi: 10.1053/j.ajkd.2014.07.026. Epub 2014 Oct 14.

PMID:
25441435
7.

Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD; HALT-PKD Trial Investigators.

N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15.

PMID:
25399731
8.

Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.

Faria B, Henriques C, Matos AC, Daha MR, Pestana M, Seelen M.

Clin Exp Immunol. 2015 Feb;179(2):354-61. doi: 10.1111/cei.12461.

PMID:
25267249
9.

Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.

Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H.

Am J Kidney Dis. 2014 Nov;64(5):730-6. doi: 10.1053/j.ajkd.2014.06.021. Epub 2014 Aug 16.

PMID:
25134778
10.

Predictors in adolescence of ESRD in middle-aged men.

Sundin PO, Udumyan R, Sjöström P, Montgomery S.

Am J Kidney Dis. 2014 Nov;64(5):723-9. doi: 10.1053/j.ajkd.2014.06.019. Epub 2014 Aug 12.

PMID:
25124945
11.

Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease.

Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ.

JAMA Intern Med. 2014 Sep;174(9):1442-9. doi: 10.1001/jamainternmed.2014.3279. Erratum in: JAMA Intern Med. 2014 Oct;174(10):1709.

12.

The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease.

Ryu J, Cha RH, Kim DK, Lee JH, Yoon SA, Ryu DR, Oh JE, Kim S, Han SY, Lee EY, Kim YS; APrODiTe investigators.

J Korean Med Sci. 2014 Jul;29(7):957-64. doi: 10.3346/jkms.2014.29.7.957. Epub 2014 Jul 11.

13.

Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.

Guessous I, McClellan W, Kleinbaum D, Vaccarino V, Zoller O, Theler JM, Paccaud F, Burnier M, Bochud M; Swiss Survey on Salt Group.

J Ren Nutr. 2014 Sep;24(5):303-12. doi: 10.1053/j.jrn.2014.04.005. Epub 2014 Jul 13.

PMID:
25030223
14.

SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial.

Rossi M, Johnson DW, Morrison M, Pascoe E, Coombes JS, Forbes JM, McWhinney BC, Ungerer JP, Dimeski G, Campbell KL.

BMC Nephrol. 2014 Jul 4;15:106. doi: 10.1186/1471-2369-15-106.

15.
16.

Hepatitis C virus infection and glomerular disease.

Fabrizi F, Donato F, Messa P.

Minerva Urol Nefrol. 2014 Jun;66(2):139-49. Review.

PMID:
24988205
17.

Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure?

Bucşa C, Stefan G, Tacu D, Sinescu I, Sinescu RD, Hârza M.

Int Urol Nephrol. 2014 Sep;46(9):1857-65. doi: 10.1007/s11255-014-0761-7. Epub 2014 Jun 20.

PMID:
24948201
18.

Staging and risk factors of chronic kidney disease of outpatients in Shanghai.

Qian Y, Ren H, Wang ZH, Li X, Chen XN, Chen N.

Ren Fail. 2014 Aug;36(7):1018-22. doi: 10.3109/0886022X.2014.926923. Epub 2014 Jun 18.

PMID:
24940809
19.

Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

Skupien J, Warram JH, Smiles A, Galecki A, Stanton RC, Krolewski AS.

J Am Soc Nephrol. 2014 Dec;25(12):2916-25. doi: 10.1681/ASN.2013091002. Epub 2014 Jun 5.

PMID:
24904086
20.

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS.

Diabetes Care. 2014 Sep;37(9):2601-8. doi: 10.2337/dc13-1983. Epub 2014 Jun 4.

PMID:
24898299
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk